Qiagen N.V.
QGENBiotechnology
$50.22−0.24%As of Oct 30vs prior close
- Market cap
- $10.4B
- P/E (TTM)
- 24.4×
- Implied growth
- 10.4%
- From 52W high
- −8.96%
- EPS (FY25)
- $1.94
- Revenue (FY25)
- $2.1B
- Net margin
- 20.33%
- Dividend yield
- 0.70%
Nomior Score
55
Steady ProfileTop 39% of the scored universe
Growth37
Quality76
Value63
Momentum38
Resilience54
Growth
+5.08%revenue a year over 9 fiscal years
FY16 $1.3BFY25 $2.1B
Connections
Revenue to profitFY25
20% of revenue became net profit, up 16 pts on a year.